Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules

Background and Introduction: Saxagliptin is a hypoglycemic drug that acts as a dipeptidyl peptidase-4 (DPP-4) inhibitor and is preferably used in the treatment of Type 2 Diabetes Mellitus (T2DM). It is safe and tolerable; however, the major disadvantage associated with it is its low bioavailability....

Descripción completa

Detalles Bibliográficos
Autores principales: Alhamhoom, Yahya, Ravi, Gundawar, Osmani, Riyaz Ali M., Hani, Umme, Prakash, Gowrav M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653823/
https://www.ncbi.nlm.nih.gov/pubmed/36364338
http://dx.doi.org/10.3390/molecules27217510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653823/
https://www.ncbi.nlm.nih.gov/pubmed/36364338
http://dx.doi.org/10.3390/molecules27217510

Ejemplares similares